Status:
UNKNOWN
Genetic Association Study Between GAD1 and Reelin Polymorphisms and GABA/Glutamate MRS in Bipolar Disorder Type 1 and Healthy Controls: SPECGENE PROJECT
Lead Sponsor:
University of Sao Paulo
Collaborating Sponsors:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18-35 years
Brief Summary
Background: The pathophysiological mechanisms of bipolar disorder are not completely clarified and several hypothesis have already been formulated including the role of monoamines, gama amino butyric ...
Eligibility Criteria
Inclusion
- Bipolar disorder type I diagnose (DSM-IV criteria)
- Medication free (4 last weeks)
Exclusion
- heavy smokers
- cannabis use
- recent alcohol abuse (14 days)
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT01237158
Start Date
October 1 2010
Last Update
August 16 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Psychiatry HCFMUSP
São Paulo, Brazil